Novel psychedelic compound 25C-NBF shows rapid antidepressant effects without addictive traits
A newly studied synthetic psychedelic compound promotes rapid structural growth in brain cells and reverses depressive behaviors in rodents. The drug, known as 25C-NBF, appears to lack the addictive qualities and sensory disruptions associated with similar recreational substances. These results were recently published in the journal Molecular Psychiatry. Depression is a widespread mental health condition that affects millions of people globally. Symptoms range from persistent low mood to a profound loss of interest in daily activities. Many conventional treatments provide inadequate relief and require weeks or months to begin working. This delayed onset has driven researchers to explore alternative options, including psychedelic drugs that might change the brain much faster. Psychedelics are gaining attention because they can act as psychoplastogens. These are substances capable of rapidly altering the physical structure of brain cells. In people with depression, parts of the brain associated with mood regulation often lose synaptic connections, which are the communication points between neurons. Psychedelic compounds are broadly categorized into different chemical classes. Tryptamines, such as psilocybin and dimethyltryptamine, naturally occur in some …







